AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Xortib 150mg Tablet

Prescription Icon
Prescription Required

Marketer

Biocon

Salt Composition

Capecitabine (150mg)

Overview Xortib 150mg Tablet

Oncaspar 150mg tablets are indicated for the management of breast, colorectal, and rectal cancers. Additional applications may be determined by a physician. This medication is administered alone or in conjunction with other therapies as part of a chemotherapy regimen. Oncaspar 150mg tablets should be ingested with food, within 30 minutes post-meal. Dosage frequency and amount will be determined by your doctor, based on your specific condition and may be adjusted. Strict adherence to your physician's prescribed regimen is crucial; improper usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, often requiring several weeks or months; discontinuation should only occur under medical supervision. Commonly reported side effects include emesis, fatigue, nausea, abdominal discomfort, and diarrhea. This medication can induce leukopenia, increasing infection vulnerability. Regular blood tests are necessary to monitor blood cell counts, along with cardiac, hepatic, and uric acid levels. Prior to commencing treatment, inform your doctor of any pre-existing hepatic or renal conditions, or concurrent use of antimicrobial medications. Potential drug interactions are numerous; disclose all medications to your physician. This medication is contraindicated during pregnancy and lactation. The use of reliable contraception by both partners is strongly advised throughout the treatment period.

Primary Ingredients of Xortib 150mg Tablet

No text was provided to rewrite.

Uses of Xortib 150mg Tablet

Carcinoma of the breast and colorectal cancer

Major Benefits of Xortib 150mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Xortib 150mg Tablet should be administered with a meal.

Common Side effects of Xortib 150mg Tablet:

  • Vomiting
  • Weakness
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Blisters on fingers/feet

How to use Xortib 150mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 150mg Xortib tablet whole; avoid crushing, chewing, or fracturing it. It should be taken with a meal.

How Xortib 150mg Tablet works:

Xortib 150mg tablets function as an antineoplastic agent. Metabolized into 5-fluorouracil, it disrupts the production of RNA and DNA within cancerous cells, inhibiting their replication and ultimately leading to cell death, thus retarding tumor growth.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Xortib 150mg tablets may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Xortib 150mg tablets is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Administration of Xortib 150mg tablets is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingUNSAFE

Taking a 150mg Xortib tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Xortib 150mg tablets; dosage modification may be necessary. Consult a physician for guidance. Xortib 150mg tablets are contraindicated in individuals with severely compromised kidney function.

LiverLiverCAUTION

Patients with liver impairment should use Xortib 150mg tablets cautiously, potentially requiring dosage modification under medical supervision. Xortib 150mg tablets are contraindicated in individuals with severe renal dysfunction.

What if you forget to take Xortib 150mg Tablet :

NA

Facts to Know About Xortib 150mg Tablet

LabelValue
Type of Compound Nucleoside analog of deoxycytidine
Potential for Dependence None.
Type of Medication Cancer therapeutics
Mechanism of Action Metabolic antagonists

FAQs on Xortib 150mg Tablet

Xortib 150mg Tablet may cause gastrointestinal distress, including abdominal pain, constipation, and anorexia. Taste alterations are also possible. Other potential side effects include polydipsia, fatigue, vertigo, cephalalgia, alopecia, dermatological reactions, musculoskeletal pain, and ocular symptoms such as redness, swelling, pruritus, lacrimation, and sleep disturbances. Report any persistent or severe side effects to your physician.
Taking Xortib 150mg Tablets can lead to several potentially severe adverse reactions. These include gastrointestinal issues like diarrhea, nausea, and vomiting; mouth sores; and skin reactions characterized by swelling, pain, redness, or peeling, particularly on the palms and soles. Furthermore, symptoms such as fever, chills, sore throat, or other infection indicators; edema in the extremities (hands, feet, ankles, or lower legs); chest discomfort or pressure; rapid heart rate; dark urine; and jaundice (yellowing of the skin or eyes) are possible. Report any of these symptoms to your physician without delay.
Fatigue and weakness are frequently reported side effects of Xortib 150mg Tablets. Consequently, driving or operating machinery while taking this medication may be impaired.
Xortib 150mg Tablets can interact negatively with anticoagulants such as warfarin, potentially altering coagulation and increasing the risk of hemorrhage, which may be fatal. This risk is amplified in cancer patients, particularly those aged 60 and above. Urgent medical attention is required if you exhibit signs of abnormal bleeding, including hematemesis (vomiting blood or coffee-ground-like material), melena (black, tarry stools), hematuria (blood in urine), dark or reddish-brown urine, or excessive bruising.
Treatment length for Xortib 150mg Tablet varies based on your condition and how you respond to the medication. The typical regimen consists of 21-day treatment cycles, each involving 14 days of Xortib 150mg Tablet followed by a 7-day break. Always adhere to your doctor's prescribed treatment duration.
Utilizing effective contraception is essential during Xortib 150mg Tablet treatment, due to the drug's potential for fetal harm. Women should maintain contraceptive practices for six months following their last dose. Similarly, male patients with partners who could conceive must employ reliable birth control throughout treatment and for three months post-treatment.
The antineoplastic chemotherapy agent Xortib 150mg Tablet is categorized as an antimetabolite. Unlike cytostatic medications, Xortib 150mg Tablet isn't directly active; its anticancer properties emerge following bodily absorption, preferentially within tumor tissue.
Your physician will conduct routine checkups during your Xortib 150mg Tablet treatment to assess side effects and treatment efficacy. Blood tests, as directed by your doctor, may be required to monitor your complete blood count (CBC), kidney function, and liver function.
Administer capecitabine orally within 30 minutes post-prandially. Tablets must be swallowed whole; avoid crushing or cutting. Patients unable to swallow whole tablets should seek medical advice. Crushing or cutting Xortib 150mg Tablets requires a trained professional employing suitable equipment and safety protocols.
Xortib 150mg Tablet
640
MRP 780
17% off